Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting oncology pipeline at 2021 ASCO Meeting Early clinical data for investigational oral selective estrogen receptor (SERD), amcenestrant, show potential to become a new endocrine backbone therapy in ER+ HER2- breast cancer Data that reinforce Libtayo (cemiplimab-rwlc) as a standard of care in advanced non-melanoma skin cancer and advanced non-small cell lung cancer, including new data in historically underrepresented patients with brain metastases Longer term data and new analyses for Sarclisa (isatuximab-ir...